# Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI

Study · id `cardio:ct-nct01642134` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01642134](<https://clinicaltrials.gov/study/NCT01642134>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01642134

Browse, organ or system: Heart; Brain  
Browse, condition area: Stroke; Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 124 participants.

## Technical summary

Registry record NCT01642134. Randomized; single masking; primary purpose treatment. Start 2013-04 (registry gives no type); primary completion 2019-06-30 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 124 participants (enrolled count; ClinicalTrials.gov record NCT01642134, source copy `cardio:ctgov-nct01642134-2019-08-09`, retrieved 2026-10-26)
- Start date: 2013-04 (registry gives no type) (ClinicalTrials.gov record NCT01642134, source copy `cardio:ctgov-nct01642134-2019-08-09`, retrieved 2026-10-26)
- Primary completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT01642134, source copy `cardio:ctgov-nct01642134-2019-08-09`, retrieved 2026-10-26)
- Completion: 2019-06-30 (actual) (ClinicalTrials.gov record NCT01642134, source copy `cardio:ctgov-nct01642134-2019-08-09`, retrieved 2026-10-26)
- Countries: Spain (ClinicalTrials.gov record NCT01642134, source copy `cardio:ctgov-nct01642134-2019-08-09`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01642134-2019-08-09`, retrieved 2026-10-26)

## The registry's words

- Brief title: Dual Antiplatelet Therapy Versus Oral Anticoagulation for a Short Time to Prevent Cerebral Embolism After TAVI
- Acronym: AUREA
- Condition: Aortic Valve Stenosis
- Condition: Stroke
- Intervention (Drug): aspirin+clopidogrel (Duoplavin)
- Lead sponsor: Andres Iñiguez Romo, MD, PhD
- Lead sponsor class: OTHER\_GOV

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 34265dff8876d480efdba06760e74e118072a9d47fc96e5d8312da0ed87a2383
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
